@article{644e60278d434ea883f4d60b589f5124,
title = "Ramucirumab for Treating Advanced Gastric Cancer or Gastro-Oesophageal Junction Adenocarcinoma Previously Treated with Chemotherapy: An Evidence Review Group Perspective of a NICE Single Technology Appraisal",
keywords = "HEALTH STATE UTILITIES, RANDOMIZED PHASE-III, SUPPORTIVE CARE, OPEN-LABEL, TRIAL, IRINOTECAN, PLUS, COMBINATION, MONOTHERAPY, PACLITAXEL",
author = "Buyukkaramikli, {Nasuh C.} and Blommestein, {Hedwig M.} and Rob Riemsma and Nigel Armstrong and Clay, {Fiona J.} and Janine Ross and Gill Worthy and Johan Severens and Jos Kleijnen and Al, {Maiwenn J.}",
year = "2017",
month = dec,
doi = "10.1007/s40273-017-0528-y",
language = "English",
volume = "35",
pages = "1211--1221",
journal = "Pharmacoeconomics",
issn = "1170-7690",
publisher = "Adis International Ltd",
number = "12",
}